Merck & Co., Inc. is a global research-driven pharmaceutical products company. Committed to bringing out the best in medicine
Contact usWorldwide
HomeAbout MerckProductsNewsroomInvestor InformationCareersResearchLicensingThe Merck Manuals

The Merck Manual--Second Home Edition logo
 
click here to go to the Index click here to go to the Table of Contents click here to go to the search page click here for purchasing information
Chapter 173. Bleeding and Clotting Disorders
Topics: Introduction | Hereditary Hemorrhagic Telangiectasia | Allergic Purpura | Thrombocytopenia | Von Willebrand's Disease | Hemophilia | Thrombophilia | Disseminated Intravascular Coagulation
 
green line

Thrombophilia

Thrombophilia is a disorder in which the blood clots easily or excessively.

Most disorders that cause thrombophilia increase the risk of blood clot formation in veins; a few increase the risk of clot formation in both arteries and veins.

Causes

Some of the disorders that cause thrombophilia are inherited. Many of these result from changes in the amount or function of certain proteins in the blood that control clotting. For example, activated protein C resistance (Factor V Leiden mutation), a specific mutation in the prothrombin gene, and a deficiency of protein C, protein S, or antithrombin all cause an increase in the production of fibrin, an important protein involved in clot formation. Hyperhomocysteinemia, an increase in the amount of homocysteine (a type of amino acid) in the blood, results in an increased risk of clotting in veins and arteries.

Other disorders that cause thrombophilia are acquired after birth. These disorders include disseminated intravascular coagulation (often associated with cancer), the presence of the lupus "anticoagulant," and antiphospholipid (anticardiolipin) syndrome, which increase the risk of clotting because of overactivation of blood clotting factors.

Other factors may increase the risk of clotting along with thrombophilia. Many involve conditions that result in a person not moving around sufficiently, causing blood to pool in the veins. Examples include paralysis, prolonged sitting (especially in confined spaces as in a car or airplane), prolonged bed rest, recent surgery, or heart attack. Heart failure, a condition in which the blood is not pumped sufficiently through the bloodstream, is a risk factor. Conditions that result in increased pressure on veins, including obesity or pregnancy, also increase risk.

Symptoms and Complications

Most of the inherited disorders do not begin to cause an increased risk of clotting until young adulthood, although clots can form at any age. Many people with inherited disorders develop a deep vein clot (deep vein thrombosis) in the legs, which can result in leg swelling. Formation of a deep leg clot may be followed by pulmonary embolism. After experiencing several deep vein clots, more serious swelling and skin discoloration may develop (chronic deep vein insufficiency). Sometimes, clots form in superficial leg veins, causing pain and redness (superficial thrombophlebitis). Less commonly, clots may form in arm veins, abdominal veins, and veins inside the skull. Hyperhomocysteinemia, the presence of the lupus "anticoagulant," and the antiphospholipid syndrome may result in venous or arterial clots. Arterial clots can damage and cause death of tissues that lose their supply of blood when clots form and obstruct blood flow.

Diagnosis and Treatment

A person who has had at least two separate instances of a blood clot may have an inherited thrombophilia disorder. An inherited disorder may also be suspected if a person with an initial blood clot has a family history of blood clots. A young healthy person who develops an initial clot for no apparent reason may have an inherited disorder.

Blood tests that measure the amount or activity of different proteins that control clotting are used to identify specific inherited disorders of thrombophilia. These tests are usually more accurate when performed after a blood clot has been treated.

The inherited disorders that cause thrombophilia are incurable. People who have had two or more clots are especially likely to be advised to take the anticoagulant warfarin for the rest of their lives. When a person has had only one clot, warfarin or heparin to prevent future clots may be used only when the person is at higher risk for clot formation, including during a period of prolonged bed rest.

People with hyperhomocysteinemia may be advised to take vitamin supplements with folic acid, vitamin B6 (pyridoxine), and vitamin B12 (cobalamin), which can reduce homocysteine levels.

Site MapPrivacy PolicyTerms of UseCopyright 1995-2004 Merck & Co., Inc.